Pharmacological inhibition of dopamine and serotonin activity blocks spontaneous and cocaine-activated behaviour

Progress in Brain Research

Volumn 172, Issue , 2008, Pages 347-360

  Carey, Robert J ^a   Huston, Joseph P ^b   Müller, Christian P ^c  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

autoreceptors; cocaine; dopamine; locomotor activity; serotonin

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; APOMORPHINE; AUTORECEPTOR; COCAINE; DOPAMINE; DOPAMINE RECEPTOR; FLESINOXAN; IPSAPIRONE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; NEUROTRANSMITTER; PSYCHOSTIMULANT AGENT; SEROTONIN; SEROTONIN RECEPTOR;

BEHAVIOR; BRAIN NERVE CELL; BRAIN REGION; CHEMICAL INTERACTION; DOPAMINERGIC SYSTEM; DOSE TIME EFFECT RELATION; DRUG DOSE COMPARISON; EMOTION; HUMAN; LOCOMOTION; LOW DRUG DOSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SEROTONINERGIC SYSTEM;

ANIMALS; AUTORECEPTORS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; HUMANS; MOTOR ACTIVITY; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 50349098755     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(08)00917-5     Document Type: Review

References (130)

1. Adell A., Celada P., Abellan M.T., and Artigas F. Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei. Brain Res. Rev. 39 (2002) 154-180
2. Aghajanian G.K., and Bunney B.S. Central dopaminergic neurons: neurophysiological identification and responses to drugs. In: Snyder S., and Usdin E. (Eds). Frontiers in Catecholamine Research (1973), Pergamon, New York 643-648
3. Agnati L.F., Zoli M., Stromberg I., and Fuxe K. Intercellular communication in the brain: wiring versus volume transmission. Neuroscience 69 (1995) 711-726
4. Ago Y., Koyama Y., Baba A., and Matsuda T. Regulation by 5-HT1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex. Neuropharmacology 45 (2003) 1050-1056
5. Arborelius L., Chergui K., Murase S., Nomikos G.G., Hook B.B., Chouvet G., Hacksell U., and Svensson T.H. The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons. Naunyn Schmiedebergs Arch. Pharmacol. 347 (1993) 353-362
6. Barnes N.M., and Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 38 (1999) 1083-1152
7. Benloucif S., and Galloway M.P. Facilitation of dopamine release in vivo by serotonin agonists - studies with microdialysis. Eur. J. Pharmacol. 200 (1991) 1-8
8. Benloucif S., Keegan M.J., and Galloway M.P. Serotonin-facilitated dopamine release in-vivo - pharmacological characterization. J. Pharmacol. Exp. Ther. 265 (1993) 373-377
9. Berger B., Gaspar P., and Verney C. Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates. Trends Neurosci. 14 (1991) 21-27
10. Bhat R.V., and Baraban J.M. Activation of transcription factor genes in striatum by cocaine - role of both serotonin and dopamine systems. J. Pharmacol. Exp. Ther. 267 (1993) 496-505
11. Blier P., and de Montigny C. Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain. Synapse 1 (1987) 470-480
12. Blier P., Lista A., and de Montigny C. Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: I. Effect of spiperone. J. Pharmacol. Exp. Ther. 265 (1993) 7-15
13. Blier P., Lista A., and de Montigny C. Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: II. Effect of pertussis and cholera toxins. J. Pharmacol. Exp. Ther. 265 (1993) 16-23
14. Blier P., Pineyro G., el Mansari M., Bergeron R., and de Montigny C. Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission. Ann. NY Acad. Sci. 861 (1998) 204-216
15. Blier P., Serrano A., and Scatton B. Differential responsiveness of the rat dorsal and median raphe 5-HT systems to 5-HT1 receptor agonists and p-chloroamphetamine. Synapse 5 (1990) 120-133
16. Bonvento G., Scatton B., Claustre Y., and Rouquier L. Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain. Neurosci. Lett. 137 (1992) 101-104
17. Bunin M.A., and Wightman R.M. Paracrine neurotransmission in the CNS: involvement of 5-HT. Trends Neurosci. 22 (1999) 377-382
18. Cameron D.L., and Williams J.T. Cocaine inhibits GABA release in the VTA through endogenous 5-HT. J. Neurosci. 14 (1994) 6763-6767
19. Carey R., Damianopoulos E., and DePalma G. The 5-HT(1A) antagonist WAY 100635 can block the low-dose locomotor stimulant effects of cocaine. Brain Res. 862 (2000) 242-246
20. Carey R.J., DePalma G., and Damianopoulos E. Cocaine and serotonin: a role for the 5-HT(1A) receptor site in the mediation of cocaine stimulant effects. Behav. Brain Res. 126 (2001) 127-133
21. Carey R.J., DePalma G., and Damianopoulos E. 5-HT1A agonist/antagonist modification of cocaine stimulant effects: implications for cocaine mechanisms. Behav. Brain Res. 132 (2002) 37-46
22. Carey R.J., DePalma G., and Damianopoulos E. 8-OHDPAT effects upon cocaine unconditioned and conditioned behaviors. A role for drug stimulus effects. Pharmacol. Biochem. Behav. 72 (2002) 171-178
23. Carey R.J., DePalma G., Damianopoulos E., Müller C.P., and Huston J.P. The 5-HT1A receptor and behavioral stimulation in the rat: effects of 8-OHDPAT on spontaneous and cocaine-induced behavior. Psychopharmacology 177 (2004) 46-54
24. Carey R.J., DePalma G., Damianopoulos E., Hopkins A., Shanahan A., Müller C.P., and Huston J.P. Dopaminergic and serotonergic autoreceptor stimulation effects are equivalent and additive in the suppression of spontaneous and cocaine induced locomotor activity. Brain Res. 1019 (2004) 134-143
25. Carey R.J., DePalma G., Damianopoulos E., Shanahan A., Müller C.P., and Huston J.P. Evidence that the 5-HT1A autoreceptor is an important pharmacological target for the modulation of cocaine behavioral stimulant effects. Brain Res. 1034 (2005) 162-171
26. Carey R.J., DePalma G., Damianopoulos E., Shanahan A., Müller C.P., and Huston J.P. Pharmacological inhibition of DA- and 5-HT activity blocks spontaneous and cocaine-activated behavior: reversal by chronic cocaine treatment. Brain Res. 1047 (2005) 194-204
27. Carey R.J., DePalma G., Damianopoulos E., and Shanahan A. Stimulus gated cocaine sensitization: interoceptive drug cue control of cocaine locomotor sensitization. Pharmacol. Biochem. Behav. 82 (2005) 353-360
28. Carey R.J., DePalma G., and Damianopoulos E. Acute and chronic cocaine behavioral effects in novel versus familiar environments: open-field familiarity differentiates cocaine locomotor stimulant effects from cocaine emotional behavioral effects. Behav. Brain Res. 158 (2005) 321-330
29. Carli M., Prontera C., and Samanin R. Effect of 5-HT1A agonists on stress-induced deficit in open field locomotor activity of rats: evidence that this model identifies anxiolytic-like activity. Neuropharmacology 28 (1989) 471-476
30. Carlsson A. Thirty years of dopamine research. Adv. Neurol. 60 (1993) 1-10
31. Casanovas J.M., and Artigas F. Differential effects of ipsapirone on 5-hydroxytryptamine release in the dorsal and median raphe neuronal pathways. J. Neurochem. 67 (1996) 1945-1952
32. Casanovas J.M., Lesourd M., and Artigas F. The effect of the selective 5-HT1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain. Br. J. Pharmacol. 122 (1997) 733-741
33. Chen N.H., and Reith M.E. Monoamine interactions measured by microdialysis in the ventral tegmental area of rats treated systemically with (+/-)-8-hydroxy-2-(di-n-propylamino) tetralin. J. Neurochem. 64 (1995) 1585-1597
34. Cox R.F., Meller E., and Waszczak B.L. Electrophysiological evidence for a large receptor reserve for inhibition of dorsal raphe neuronal firing by 5-HT(1A) agonists. Synapse 14 (1993) 297-304
35. De La Garza R.D., and Cunningham K.A. The effects of the 5-hydroxytryptamine(1A) agonist 8-hydroxy-2-(di-n-propylamino)tetralin on spontaneous activity, cocaine-induced hyperactivity and behavioral sensitization: a microanalysis of locomotor activity. J. Pharmacol. Exp. Ther. 292 (2000) 610-617
36. Dekeyne A., Brocco M., Adhumeau A., Gobert A., and Millan M.J. The selective serotonin (5-HT)(1A) receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats - a comparison with other anxiolytic agents. Psychopharmacology 152 (2000) 55-66
37. Depoortere R., Perrault G., and Sanger D.J. Behavioural effects in the rat of the putative dopamine D3 receptor agonist 7-OH-DPAT: comparison with quinpirole and apomorphine. Psychopharmacology 124 (1996) 231-240
38. Devoto P., Flore G., Pani L., and Gessa G. Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex. Mol. Psychiatr. 6 (2001) 657-664
39. Devoto P., Flore G., Saba P., Fa M., and Gessa G.L. Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex. J. Neurochem. 92 (2005) 368-374
40. Di Chiara G., Porceddu M.L., Fratta W., and Gessa G.L. Postsynaptic receptors are not essential for dopaminergic feedback regulation. Nature 267 (1977) 270-272
41. Doherty M.D., and Pickel V.M. Targeting of serotonin1A receptors to dopaminergic neurons within the parabrachial subdivision of the ventral tegmental area in rat brain. J. Comp. Neurol. 433 (2001) 390-400
42. Dourish C.T., Hutson P.H., and Curzon G. Characteristics of feeding induced by the serotonin agonist "8-hydroxy-2-(di-normal-propylamino) tetralin (8-OH-DPAT). Brain Res. Bull. 15 (1985) 377-384
43. Elliott P.J., Walsh D.M., Close S.P., Higgins G.A., and Hayes A.G. Behavioural effects of serotonin agonists and antagonists in the rat and marmoset. Neuropharmacology 29 (1990) 949-956
44. Evenden J.L., and Ängeby-Möller K. Effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on locomotor activity and rearing of mice and rats. Psychopharmacology 102 (1990) 485-491
45. Ferre S., Cortes R., and Artigas F. Dopaminergic regulation of the serotonergic raphe-striatal pathway - microdialysis studies in freely moving rats. J. Neurosci. 14 (1994) 4839-4846
46. Fornal C.A., Marrosu F., Metzler C.W., Tada K., and Jacobs B.L. Effects of the putative 5-hydroxytryptamine(1A) antagonists BMY-7378, NAN-190 and (-)-propranolol on serotonergic dorsal raphe unit-activity in behaving cats. J. Pharmacol. Exp. Ther. 270 (1994) 1359-1366
47. Fornal C.A., Metzler C.W., Gallegos R.A., Veasey S.C., McCreary A.C., and Jacobs B.L. WAY-100635, a potent and selective 5-hydroxytryptamine(1A) antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135. J. Pharmacol. Exp. Ther. 278 (1996) 752-762
48. Golembiowska K., and Wedzony K. Enhancement by ipsapirone of dopamine release in the rat striatum. Pol. J. Pharmacol. 45 (1993) 299-308
49. Gozlan H., El-Mestikawy S., Pichat L., Glowinski J., and Hamon M. Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature 305 (1983) 140-142
50. Guan X.M., and McBride W.J. Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release. Brain Res. Bull. 23 (1989) 541-547
51. Hall F.S., Sora I., Drgonova J., Li X.F., Goeb M., and Uhl G.R. Molecular mechanisms underlying the rewarding effects of cocaine. Ann. NY Acad. Sci. 1025 (2004) 47-56
52. Hamon M., Gozlan H., el Mestikawy S., Emerit M.B., Bolanos F., and Schechter L. The central 5-HT1A receptors: pharmacological, biochemical, functional, and regulatory properties. Ann. NY Acad. Sci. 600 (1990) 114-129
53. Herges S., and Taylor D.A. Involvement of serotonin in the modulation of cocaine-induced locomotor activity in the rat. Pharmacol. Biochem. Behav. 59 (1998) 595-611
54. Herges S., and Taylor D.A. Modulatory effect of p-chlorophenylalanine microinjected into the dorsal and median raphe nuclei on cocaine-induced behavior in the rat. Eur. J. Pharmacol. 374 (1999) 329-340
55. Herges S., and Taylor D.A. Modulation of cocaine-induced locomotor activity, rears and head bobs by application of WAY100635 into the dorsal and median raphe nuclei of the rat. Naunyn Schmiedebergs Arch. Pharmacol. 360 (1999) 129-134
56. Herve D., Pickel V.M., Joh T.H., and Beaudet A. Serotonin axon terminals in the ventral tegmental area of the rat-fine-structure and synaptic input to dopaminergic-neurons. Brain Res. 435 (1987) 71-83
57. Higgins G.A., and Elliott P.J. Differential behavioural activation following intra-raphe infusion of 5-HT1A receptor agonists. Eur. J. Pharmacol. 193 (1991) 351-356
58. Hillegaart V., and Hjorth S. Median raphe, but not dorsal raphe, application of the 5-HT1A agonist 8-OH-DPAT stimulates rat motor activity. Eur. J. Pharmacol. 160 (1989) 303-307
59. Hillegaart V., Wadenberg M.L., and Ahlenius S. Effects of 8-OH-DPAT on motor activity in the rat. Pharmacol. Biochem. Behav. 32 (1989) 797-800
60. Hjorth S., and Magnusson T. The 5-HT1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo. Naunyn Schmiedebergs Arch. Pharmacol. 338 (1988) 463-471
61. Hornykiewicz O. Dopamine and brain functions. Pharmacol. Rev. 18 (1966) 925-964
62. Hoyer D., Hannon J.P., and Martin G.R. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol. Biochem. Behav. 71 (2002) 533-554
63. Hutson P.H., Sarna G.S., O'Connell M.T., and Curzon G. Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OHDPAT into the nucleus raphe dorsalis. Neurosci. Lett. 100 (1989) 276-280
64. Invernizzi R., Carli M., Di Clemente A., and Samanin R. Administration of 8-hydroxy-2-(di-n-propylamino)tetralin in raphe nuclei dorsalis and medianus reduces serotonin synthesis in the rat brain: differences in potency and regional sensitivity. J. Neurochem. 56 (1991) 243-247
65. Jackson D.M., Wallsten C.E., Jerning E., Hu P.S., and Deveney A.M. Two selective 5-HT1A receptor antagonists, WAY-100 635 and NDL-249, stimulate locomotion in rats acclimatised to their environment and alter their behaviour: a behavioural analysis. Psychopharmacology 139 (1998) 300-310
66. Jacobs B.L., and Azmitia E.C. Structure and function of the brain serotonin system. Physiol. Rev. 72 (1992) 165-229
67. Jacobs B.L., and Fornal C.A. 5-HT and motor control. Trends Neurosci. 16 (1993) 346-352
68. Jacobs B.L., Wilkinson L.O., and Fornal C.A. The role of brain serotonin. Neuropsychopharmacology 3 (1990) 473-479
69. King G.R., Joyner C., Lee T.H., and Ellinwood E.H. Withdrawal from continuous or intermittent cocaine-effects of NAN-190 on cocaine-induced locomotion. Pharmacol. Biochem. Behav. 44 (1993) 253-262
70. Koe B.K. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J. Pharmacol. Exp. Ther. 199 (1976) 649-661
71. Koob G.F., Sanna P.P., and Bloom F.E. Neuroscience of addiction. Neuron 21 (1998) 467-476
72. Kreiss D.S., and Lucki I. Differential regulation of serotonin (5-HT) release in the striatum and hippocampus by 5-HT1A autoreceptors of the dorsal and median raphe nuclei. J. Pharmacol. Exp. Ther. 269 (1994) 1268-1279
73. Lakoski J.M., and Cunningham K.A. Cocaine interaction with central monoaminergic systems: electrophysiological approaches. Trends Pharmacol. Sci. 9 (1988) 177-180
74. Lechin F., Van der Dijs B., and Hernandez-Adrian G. Dorsal raphe vs. median raphe serotonergic antagonism. Anatomical, physiological, behavioral, neuroendocrinological, neuropharmacological and clinical evidences: relevance for neuropharmacological therapy. Prog. Neuropsychopharm. Biol. Psych. 30 (2006) 565-585
75. Lejeune F., and Millan M.J. Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535. Synapse 30 (1998) 172-180
76. Lucki I., Ward H.R., and Frazer A. Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity. J. Pharmacol. Exp. Ther. 249 (1989) 155-164
77. Martin L.P., Jackson D.M., Wallsten C., and Waszczak B.L. Electrophysiological comparison of 5-hydroxytryptamine(1A) receptor antagonists on dorsal raphe cell firing. J. Pharmacol. Exp. Ther. 288 (1999) 820-826
78. McBride W.J., Murphy J.M., and Ikemoto S. Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies. Behav. Brain Res. 101 (1999) 129-152
79. Meller E., Goldstein M., and Bohmaker K. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists. Mol. Pharmacol. 37 (1990) 231-237
80. Meneses A. 5-HT system and cognition. Neurosci. Biobehav. Rev. 23 (1999) 1111-1125
81. Missale C., Nash S.R., Robinson S.W., Jaber M., and Caron M.G. Dopamine receptors: from structure to function. Physiol. Rev. 78 (1998) 189-225
82. Mittman S.M., and Geyer M.A. Effects of 5HT-1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens. Psychopharmacology 98 (1989) 321-329
83. Molina P.E., Ahmed N., Gatley J., Volkow N.D., and Abumrad N.N. l-tryptophan attenuation of the dopaminergic and behavioral responses to cocaine. Life Sci. 69 (2001) 1897-1906
84. Morrow B.A., and Roth R.H. Serotonergic lesions alter cocaine-induced locomotor behavior and stress-activation of the mesocorticolimbic dopamine system. Synapse 23 (1996) 174-181
85. Müller C.P., and Carey R.J. Intracellular 5-HT2C-receptor dephosphorylation: a new target for treating drug addiction. Trends Pharmacol. Sci. 27 (2006) 455-458
86. Müller C.P., De Souza-Silva M.A., DePalma G., Tomaz C., Carey R.J., and Huston J.P. The selective serotonin1A-receptor antagonist WAY 100635 blocks behavioral stimulating effects of cocaine but not ventral striatal dopamine increase. Behav. Brain Res. 134 (2002) 337-346
87. Müller C.P., Carey R.J., de Souza Silva M.A., Jocham G., and Huston J.P. Cocaine increases serotonergic activity in the hippocampus and nucleus accumbens in vivo: 5HT1A-receptor antagonism blocks behavioral but potentiates serotonergic activation. Synapse 45 (2002) 67-77
88. Müller C.P., Carey R.J., Huston J.P., and de Souza Silva M.A. Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors. Prog. Neurobiol. 81 (2007) 133-178
89. Müller C.P., Carey R.J., Salloum J.B., and Huston J.P. Serotonin(1A)-receptor agonism attenuates the cocaine-induced increase in serotonin levels in the hippocampus and nucleus accumbens but potentiates hyperlocomotion: an in vivo microdialysis study. Neuropharmacology 44 (2003) 592-603
90. Müller C.P., and Huston J.P. Dissecting region-specific interactions of serotonin receptors with the psychostimulant effects of cocaine. Trends Pharmacol. Sci. 27 (2006) 105-112
91. Müller C.P., and Huston J.P. Dopamine activity in the occipital and temporal cortex of rats: dissociating effects of sensory but not pharmacological stimulation. Synapse 61 (2007) 254-258
92. Nakamura S., Ago Y., Hayashi A., Itho S., Kakuda M., Hashimoto H., Baba A., and Matsuda T. Modification of cocaine-induced behavioral and neurochemical effects by serotonin1A receptor agonist/antagonst in mice. Synapse 60 (2006) 479-484
93. Newman A.H., Allen A.C., Izenwasser S., and Katz J.L. Novel 3 alpha-(diphenylmethoxy)tropane analogs: potent dopamine uptake inhibitors without cocaine-like behavioral profiles. J. Med. Chem. 37 (1994) 2258-2261
94. Nomikos G.G., Arborelius L., Hook B.B., Hacksell U., and Svensson T.H. The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum. J. Neural. Transm. 103 (1996) 541-554
95. Pessia M., Jiang Z.G., North R.A., and Johnson S.W. Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in-vitro. Brain Res. 654 (1994) 324-330
96. Pitts D.K., and Marwah J. Electrophysiological effects of cocaine on central monoaminergic neurons. Eur. J. Pharmacol. 131 (1986) 95-98
97. Pitts D.K., and Marwah J. Cocaine modulation of central monoaminergic neurotransmission. Pharmacol. Biochem. Behav. 26 (1987) 453-461
98. Pradhan S.N., Battacharyya A.K., and Pradhan S. Serotoninergic manipulation of the behavioral effects of cocaine in rats. Commun. Psychopharmacol. 2 (1978) 481-486
99. Przegalinski E., and Filip M. Stimulation of serotonin (5-HT)1A receptors attenuate the locomotor, but not the discriminative, effects of amphetamine and cocaine in rats. Behav. Pharmacol. 8 (1997) 699-706
100. Riad M., Garcia S., Watkins K.C., Jodoin N., Doucet E., Langlois X., El-Mestikawy S., Hamon M., and Descarries L. Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain. J. Comp. Neurol. 417 (2000) 181-194
101. Riad M., Watkins K.C., Doucet E., Hamon M., and Descarries L. Agonist-induced internalization of serotonin-1A receptors in the dorsal raphe nucleus (autoreceptors) but not hippocampus (heteroreceptors). J. Neurosci. 21 (2001) 8378-8386
102. Ross S.B., and Renyi A.L. Inhibition of uptake of tritiated catecholamines by antidepressant and related agents. Eur. J. Pharmacol. 2 (1967) 181-186
103. Ross S.B., and Renyi A.L. Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue. Eur. J. Pharmacol. 7 (1969) 270-277
104. Rothman R.B., Baumann M.H., Dersch C.M., Romero D.V., Rice K.C., Carroll F.I., and Partilla J.S. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39 (2001) 32-41
105. Rothman R.B., Grieg N., Kim A., De Costa B., Rice K.C., Carroll F.I., and Pert A. Cocaine and GBR12909 produce equivalent motoric responses at different occupancy of the dopanmine transporter. Pharmacol. Biochem. 39 (1992) 1135-1142
106. Rutter J.J., Gundlah C., and Auerbach S.B. Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation. Synapse 20 (1995) 225-233
107. Schultz W. Predictive reward signal of dopamine neurons. J. Neurophysiol. 80 (1998) 1-27
108. Sharp T., Bramwell S.R., and Grahame-Smith D.G. 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br. J. Pharmacol. 96 (1989) 283-290
109. Sharp T., and Hjorth S. Application of brain microdialysis to study the pharmacology of the 5-HT1A autoreceptor. J. Neurosci. Methods 34 (1990) 83-90
110. Shim I., Javaid J., and Wirtshafter D. Dissociation of hippocampal serotonin release and locomotor activity following pharmacological manipulations of the median raphe nucleus. Behav. Brain Res. 89 (1997) 191-198
111. Sprouse J.S., and Aghajanian G.K. Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse 1 (1987) 3-9
112. Sprouse J.S., and Aghajanian G.K. Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons. Neuropharmacology 27 (1988) 707-715
113. Stamford J.A., Davidson C., McLaughlin D.P., and Hopwood S.E. Control of dorsal raphe 5-HT function by multiple 5-HT1 autoreceptors: parallel purposes or pointless plurality?. Trends. Neurosci. 23 (2000) 459-465
114. Szumlinski K.K., Frys K.A., and Kalivas P.W. Dissociable roles for the dorsal and median raphe in the facilitatory effect of 5-HT1A receptor stimulation upon cocaine-induced locomotion and sensitization. Neuropsychopharmacology 29 (2004) 1675-1687
115. Szumlinski K.K., Maisonneuve I.M., and Glick S.D. Differential effects of ibogaine on behavioural and dopamine sensitization to cocaine. Eur. J. Pharmacol. 398 (2000) 259-262
116. Szumlinski K.K., McCafferty C.A., Maisonneuve I.M., and Glick S.D. Interactions between 18-methoxycoronasidine (18-MC) and cocaine: dissociation of behavioural and neurochemical sensitization. Brain Res. 871 (2000) 245-258
117. Thiel C.M., Huston J.P., and Schwarting R.K. Cholinergic activation in frontal cortex and nucleus accumbens related to basic behavioral manipulations: handling, and the role of post-handling experience. Brain Res. 812 (1998) 121-132
118. Thiel C.M., Müller C.P., Huston J.P., and Schwarting R.K. Auditory noise can prevent increased extracellular acetylcholine levels in the hippocampus in response to aversive stimulation. Brain Res. 882 (2000) 112-119
119. Tran-Nguyen L.T.L., Baker D.A., Grote K.A., Solano J., and Neisewander J.L. Serotonin depletion attenuates cocaine-seeking behavior in rats. Psychopharmacology 146 (1999) 60-66
120. Tricklebank M.D., Middlemiss D.N., and Neill J. Pharmacological analysis of the behavioural and thermoregulatory effects of the putative 5-HT1 receptor agonist, RU 24969, in the rat. Neuropharmacology 25 (1986) 877-886
121. Valentini V., Cacciapaglia F., Frau R., and Di Chiara G. Selective serotonin reuptake blockade increases extracellular dopamine in noradrenalinerich isocortical but not prefrontal areas: dependence on serotonin-1A receptors and independence from noradrenergic innervation. J. Neurochem. 93 (2005) 371-382
122. Valentini V., Frau R., and Di Chiara G. Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine. J. Neurochem. 88 (2004) 917-927
123. Van Bockstaele E.J., Cestari D.M., and Pickel V.M. Synaptic structure and connectivity of serotonin terminals in the ventral tegmental area - potential sites for modulation of mesolimbic dopamine neurons. Brain Res. 647 (1994) 307-322
124. Van Bockstaele E.J., and Pickel V.M. GABA-containing neurons in the ventral tegmental area project to the nucleus-accumbens in rat-brain. Brain Res. 682 (1995) 215-221
125. Van der Maelen C.P., Matheson G.K., Wilderman R.C., and Patterson L.A. Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a nonbenzodiazepine anxiolytic drug. Eur. J. Pharmacol. 129 (1986) 123-130
126. Verge D., Daval G., Patey A., Gozlan H., Elmestikawy S., and Hamon M. Presynaptic 5-HT autoreceptors on serotonergic cell-bodies and or dendrites but not terminals are of the 5-HT1A subtype. Eur. J. Pharmacol. 113 (1985) 463-464
127. Wise R.A. Brain reward circuitry: insights from unsensed incentives. Neuron 36 (2002) 229-240
128. Yano M., and Steiner H. Methylphenidate and cocaine: the same effects on gene regulation?. Trends Pharmacol. Sci. 28 (2007) 588-596
129. Yoshimoto K., and McBride W.J. Regulation of nucleus accumbens dopamine release by the dorsal raphe nucleus in the rat. Neurochem. Res. 17 (1992) 401-407
130. Zoli M., Torri C., Ferrari R., Jansson A., Zini I., Fuxe K., and Agnati L.F. The emergence of the volume transmission concept. Brain Res. Rev. 26 (1998) 136-147